SCHEMBL25232419

SCHEMBL25232419

CCC(=O)NCc1nn(-c2ccc(OC(F)(F)F)cc2)c2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 3/20 0.61
▸ TEAD4 Q15561 3/20 0.61
▸ TEAD2 Q15562 3/20 0.61
▸ TEAD3 Q99594 3/20 0.61
▸ PTGER4 P35408 2/20 0.45
▸ CYP1A2 P05177 3/20 0.45
▸ CYP2C9 P11712 3/20 0.45
▸ GRIA2 P42262 1/20 0.45
▸ ABCB1 P08183 1/20 0.43
▸ SCN9A Q15858 2/20 0.41
▸ PPARG P37231 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ GLS O94925 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ RCE1 Q9Y256 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30469096 1.00 TEAD1 (0.61) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL30431649 0.90 TEAD1 (0.66) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL25237436 0.90 TEAD1 (0.66) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL25749012 0.89 TEAD1 (0.63) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL25750434 0.89 TEAD1 (0.62) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL25237292 0.88 TEAD1 (0.61) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL25247529 0.87 TEAD1 (0.60) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL30469077 0.86 LMNA (0.50) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL25274909 0.86 LMNA (0.50) TEAD1TEAD4TEAD2TEAD3PTGER4
SCHEMBL30431703 0.84 TEAD1 (0.57) TEAD1TEAD4TEAD2TEAD3PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122782-A2 INDOLES, INDAZOLES, AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 — — WO disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD2, TEAD3 TEAD1 4/4885TEAD4 5/4885TEAD2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback